South-Eastern Norway Regional Health Authority Grant 2021031 (2023-2026) INDIRECT: Imaging drug delivery in brain cancer by the intrathecal route
The Research Council of Norway and The Norwegian Cancer Society Research Grant 328827 (2022-2030) MATRIX: Multimodal Approach Targeting treatment Refractory Cancers usIng neXt generation technology (Co-lead Work Package 1)
Horizon TMA Marie Skłodowska-Curie Fellowship Grant 101068340 (2023-2026) GLIOBID: Guiding glioblastoma treatments by decrypting tumor biomechanics via Magnetic Resonance Elastography
The Research Council of Norway Project for Scientific Renewal Grant 325971 (2022-2026) TrackGrowth: Tracking cancer growth by intelligent displacement biomaps
The Research Council of Norway BEHANDLING Grant 303249 and the Norwegian Cancer Society (2020-2024) IMAGINE: Imaging molecular mechanisms of angiogenesis in glioma-associated neovasculature
South-Eastern Norway Regional Health Authority Grant 2021057 (2021-2024) CHRONOS: Predicting glioma tumor progression and their relationship with proliferation, […]
European Research Council (ERC) Starting Grant 758657 (2018-2023) ImPRESS - Imaging Perfusion Restrictions Extracellular Solid Stress
South-Eastern Norway Regional Health Authority Extended Career Grant 2017073 (2017-2023) FORCE - Functional imaging Of vascular Restrictions in CancEr
Luque L, Skogen K, MacIntosh BJ, Emblem KE, Larsson C, Bouget D, Helland RH, Reinertsen I, Solheim O, Schellhorn T, Vardal J, Mireles EEM, Vik-Mo EO, Bjørnerud A(2024) Standardized evaluation of the extent of resection in glioblastoma with automated early post-operative segmentation Front Radiol, 4, 1357341 DOI 10.3389/fradi.2024.1357341, PubMed 38840717
Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P(2024) The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients J Neurooncol, 169(1), 137-145 DOI 10.1007/s11060-024-04709-z, PubMed 38762830
Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P(2023) Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study Neurooncol Pract, 11(1), 36-45 DOI 10.1093/nop/npad063, PubMed 38222046